- GYRE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Gyre Therapeutics (GYRE) S-3Shelf registration
Filed: 26 Nov 13, 12:00am
Exhibit 12.1
Targacept, Inc.
Computation of Ratio of Earnings to Fixed Charges
Ratio of Earnings to Fixed Charges
Fiscal Year Ended December 31, | Nine Months Ended | |||||||||||||||||||||||
2008 | 2009 | 2010 | 2011 | 2012 | September 30, 2013 | |||||||||||||||||||
(in thousands, except ratio) | ||||||||||||||||||||||||
Pretax income from operations | $ | (28,144 | ) | $ | (40,325 | ) | $ | 13,115 | $ | (9,745 | ) | $ | (8,138 | ) | $ | (33,908 | ) | |||||||
Add fixed charges | 964 | 930 | 883 | 958 | 758 | 116 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total Earnings | $ | (27,180 | ) | $ | (39,395 | ) | $ | 13,998 | $ | (8,787 | ) | $ | (7,380 | ) | $ | (33,792 | ) | |||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Interest Expense | 251 | 217 | 153 | 132 | 86 | 43 | ||||||||||||||||||
Estimate of the interest within rental expense* | 713 | 713 | 730 | 826 | 672 | 73 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total Fixed Charges | $ | 964 | $ | 930 | $ | 883 | $ | 958 | $ | 758 | $ | 116 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Ratio of earnings to fixed charges | 15.85 | — | — | — | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Deficiency of earnings to fixed charges | $ | (28,144 | ) | $ | (40,325 | ) | $ | — | $ | (9,745 | ) | $ | (8,138 | ) | $ | (33,908 | ) | |||||||
|
|
|
|
|
|
|
|
|
|
|
|
* | Estimated to be one-third of rental payment. |